BIZTRAC BETA
COMPANY REGISTER PROFILE
877130622 ORG. NO. 2025 ACCOUNTS 8 SECTIONS
Active UPDATED 02.09.2026
Activities of charities which distribute means themselves

GERTRUDE OG JACK NELSONS FOND FOR STUDIER INNEN KLINISK FARMAKOLOGI STI

Org. no. 877130622 Foundation (STI) Incorporated 1980 Active
Ownership graph ↗
Revenue 2025 NOK 401,000
Operating profit NOK 374,000
Equity NOK 5.4m
Incorporated 1980
Share capital NOK 1.5m

GERTRUDE OG JACK NELSONS FOND FOR STUDIER INNEN KLINISK FARMAKOLOGI STI is registered as a foundation with organisation number 877130622. The business is classified under activities of charities which distribute means themselves (NACE 94.991). The company was incorporated in 1980. Registered share capital is NOK 1.5m. The most recent filed accounts, for the 2025 financial year, show NOK 401,000 in revenue and NOK 374,000 in operating profit.

Former names: GERTRUDE OG JACK NELSONS FOND FOR STUDIUM AV NYRESYKDOMMER M.M.

Key figures · 2025

Revenue
NOK 401,000
Operating profit
NOK 374,000
Equity
NOK 5.4m
Est. value
NOK 4.1m

Financial health · 2025

Liquidity
Not available
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
100.0%
Very good
Equity as a share of total capital

Who owns GERTRUDE OG JACK NELSONS FOND FOR STUDIER INNEN KLINISK FARMAKOLOGI STI?

No shareholders are registered for GERTRUDE OG JACK NELSONS FOND FOR STUDIER INNEN KLINISK FARMAKOLOGI STI in open Norwegian sources. Shareholder data exists mainly for limited companies (AS/ASA).

Frequently asked questions about GERTRUDE OG JACK NELSONS FOND FOR STUDIER INNEN KLINISK FARMAKOLOGI STI

What is the revenue of GERTRUDE OG JACK NELSONS FOND FOR STUDIER INNEN KLINISK FARMAKOLOGI STI?

GERTRUDE OG JACK NELSONS FOND FOR STUDIER INNEN KLINISK FARMAKOLOGI STI had revenue of NOK 401,000 in 2025.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.